Do you think the solution is better software, or is real blocker on the business/policy/cultural/incentives side? Inspired by that series I looked into building a better front end for clinical trials.gov but after seeing a few organizations try similar approaches without (yet) nailing it, I became convinced that I’d become one more classic naive-technologist story.

But have the existing approaches really missed a low hanging solution, even if it’s partial and maybe impossible to monetize?